论文信息 - Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes. - 字舞流文

Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes.

P. Ross-Macdonald | T. Choueiri | M. Fishman | M. Harrison | E. Plimack | C. Drake | S. Chasalow | M. Sznol | D. McNeel | H. Kluger | L. Appleman | W. Stadler | B. Escudier | L. Fong | J. Pérez-Gracia | D. McDermott | B. Curti | J. Simon | D. Walker | Tina C. Young